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knockout mice exhibit deficits in strong thermal stimulus
detection and inflammatory thermal hypersensitivity,
confirming a prominent role for VR1 in thermal transduc-
tion, particularly in mediating inflammatory hyperalgesia
(Caterina et al., 2000; Davis et al., 2000).
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One Baylor Plaza Cyclic AMP-dependent protein kinase (PKA) in pri-
mary afferents plays a major role in producing inflamma-Houston, Texas 77030
2 Department of Cell and Molecular Physiology and tory hyperalgesia (Levine and Reichling, 1999). Prosta-
glandins, such as PGE2, produce hyperalgesia by raisingThe Neuroscience Center
University of North Carolina, Chapel Hill intracellular cAMP levels and activating PKA in nocicep-
tive afferents (Taiwo et al., 1989; Taiwo and Levine,Chapel Hill, North Carolina 27599
1991). Conversely, mu-opioid agonists mediate periph-
eral analgesia by diminishing cAMP levels (Levine and
Taiwo, 1989). Direct activation of PKA with cAMP ana-Summary
logs also results in behavioral hypersensitivity (Taiwo et
al., 1989; Taiwo and Levine, 1991). Mice deficient in aThe capsaicin receptor, VR1 (also known as TRPV1),
is a ligand-gated ion channel expressed on nociceptive PKA regulatory subunit exhibit reduced PGE2 and forma-
lin-induced inflammatory hypersensitivity (Malmberg etsensory neurons that responds to noxious thermal and
chemical stimuli. Capsaicin responses in sensory neu- al., 1997).
The prominent roles of VR1 and PKA in inflammatoryrons exhibit robust potentiation by cAMP-dependent
protein kinase (PKA). In this study, we demonstrate hyperalgesia suggest that PKA potentiation of VR1 func-
tion may be a molecular event involved in the productionthat PKA reduces VR1 desensitization and directly
phosphorylates VR1. In vitro phosphorylation, phos- of thermal hypersensitivity. Consistent with this hypoth-
esis, PKA activation amplifies capsaicin currents andphopeptide mapping, and protein sequencing of VR1
cytoplasmic domains delineate several candidate PKA enhances capsaicin-induced peptide release in cultured
dorsal root ganglion neurons (Hingtgen et al., 1995; Huphosphorylation sites. Electrophysiological analysis of
phosphorylation site mutants clearly pinpoints Ser116 et al., 2002; Lopshire and Nicol, 1998). Recent studies
have reported conflicting results concerning PKA modu-as the residue responsible for PKA-dependent modu-
lation of VR1. Given the significant roles of VR1 and lation of VR1 responses (De Petrocellis et al., 2001; Lee
et al., 2000). It remains uncertain whether PKA can mod-PKA in inflammatory pain hypersensitivity, VR1 phos-
phorylation at Ser116 by PKA may represent an impor- ulate and phosphorylate VR1. In this study, we demon-
strate that PKA activation phosphorylates VR1 and pre-tant molecular mechanism involved in the regulation
of VR1 function after tissue injury. vents VR1 desensitization. We identify several candidate
PKA phosphorylation sites using in vitro phosphoryla-
tion and protein sequencing. Using patch-clamp elec-Introduction
trophysiology of putative phosphorylation site mutants,
we pinpoint Ser116 as the primary site responsible forVanilloid receptor 1 (VR1 or TRPV1), cloned as a capsa-
icin receptor, is a polymodal ligand-gated ion channel PKA-mediated regulation of VR1 desensitization.
that also responds to heat, protons, anandamide, and
leukotrienes (Caterina et al., 1997; Hwang et al., 2000; Results
Tominaga et al., 1998; Zygmunt et al., 1999). Several
features of VR1 initially focused attention to a significant PKA Reverses Desensitization and
role in thermal sensation and hyperalgesia. VR1 is local- Phosphorylates VR1 in Transfected Cells
ized to small diameter predominately nociceptive pri- Capsaicin activates robust inward currents in CHO-K1
mary afferents and responds to thermal stimuli in the cells expressing wild-type VR1. These responses exhibit
behaviorally noxious range (Caterina et al., 1997). Remi- dramatic desensitization during agonist application, of-
niscent of the response properties of polymodal noci- ten termed acute desensitization, as well as upon subse-
ceptive afferents, VR1 is also capable of integrating quent reapplication of agonist, commonly denoted as
thermal and chemical stimuli, such as protons or leuko- tachyphylaxis (Figure 1A, upper record). These desensi-
trienes (Hwang et al., 2000; Tominaga et al., 1998). In tization kinetics mimic native capsaicin responses in rat
response to these various stimuli, vanilloid receptors DRG neurons (Docherty et al., 1996; Koplas et al., 1997).
depolarize nociceptive afferents and can initiate inflam- Elevation of cyclic AMP levels in these cells by preincu-
matory peptide release from primary afferent nerve ter- bation (10–30 min) with the membrane permeant analogs
minals (Szallasi and Blumberg, 1999). Thus, the receptor CPT-cAMP (10M, data not shown) or 8Br-cAMP (1 mM,
may act as a thermal and chemical transducer and con- Figure 1A lower panel) greatly inhibits desensitization
tribute to neurogenic aspects of inflammation. VR1 during capsaicin application and with subsequent appli-
cations.
To assess whether the inhibition of desensitization by3 Corresondence: rgereau@bcm.tmc.edu
4 These authors contributed equally to this work. cAMP analogs reflected stimulation of PKA-mediated
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Figure 1. Regulation of VR1 Desensitization
by PKA Phosphorylation
(A) Inward current responses to consecutive
applications of 1 M capsaicin in CHO-K1
cells stably expressing wild-type VR1. The
upper responses are from a control cell, while
the lower responses are from a cell preincu-
bated for 30 min in 1 mM 8Br-cAMP. (B) The
ratio (mean  SEM) of the second to the first
of two consecutive 20 s applications of 1 M
capsaicin is plotted for CHO-K1 cells ex-
pressing wild-type VR1 under control condi-
tions, following 30 min preincubation with
1 mM 8Br-cAMP, or following 8Br-cAMP in-
cubation in the presence of 1 M H-89 (gray
bar). Asterisks indicate difference versus
control (ANOVA, post hoc Tukey’s compari-
sons, p  0.05). (C) VR1 was immunoprecipi-
tated from transiently transfected, 32P-ortho-
phosphate-labeled COS7 cells and separated
by SDS-PAGE. Bands were detected by
phosphorimaging. In the basal condition
(control), VR1 is strongly phosphorylated.
This phosphorylation is dramatically reduced
by stimulation of the cells with capsaicin
(1 M, 5 min). 8Br-cAMP (1 mM, 15 min pre-
treatment) did not significantly increase basal
phosphorylation, but blunted capsaicin-
induced dephosphorylation. (D) Quantifica-
tion of phosphorimager results using densi-
tometry from four experiments. ANOVA, post
hoc Tukey’s comparisons, * versus control,
 bracketed groups, p  0.05.
phosphorylation, we examined the effect of PKA inhibi- capsaicin treatment. A desensitizing capsaicin applica-
tion induced robust dephosphorylation, which was sig-tors on the phenomenon. The magnitude of desensitiza-
tion was assessed in the form historically termed tachy- nificantly blunted by pre-treatment with 8Br-cAMP (Fig-
ures 1C and 1D). These data suggest that PKA directlyphylaxis by measuring the ratio of currents induced by
the second of two 20 s applications of capsaicin (1 M) phosphorylates VR1 and regulates desensitization.
to those induced by the initial application of capsaicin.
As expected, the marked desensitization seen under VR1 Cytoplasmic Domains Are In Vitro
PKA Substratescontrol conditions for capsaicin (Figure 1B, open bar)
was absent following preincubation with 1 mM 8Br- In order to identify candidate VR1 PKA phosphorylation
sites, we produced bacterial, GST fusion proteins of thecAMP (Figure 1B, black bar). In contrast, preincubation
with 8Br-cAMP in the presence of the PKA inhibitor, H89, N- and C-terminal cytoplasmic domains and a synthetic
peptide corresponding to the first intracellular loop toresulted in desensitization similar to untreated control
(Figure 1B, gray bar). Similar results were observed us- utilize as in vitro PKA phosphorylation reaction sub-
strates (Figures 2A and 2B). The second intracellularing the PKA inhibitor Rp-cAMPS (data not shown). These
data suggest that VR1 can be maintained in a sensitized loop was omitted since it does not contain any serines
or threonines. All of the engineered proteins acted asfunctional state and/or rescued from desensitization by
PKA-mediated phosphorylation. in vitro substrates for PKA with saturating time courses
(Figures 2C–2E).Since PKA activation modulates VR1 function, we
wanted to determine whether VR1 was directly phos- We utilized classic HPLC and Edman based tech-
niques as well as ESI mass spectroscopy to delineatephorylated by PKA. VR1, immunoprecipitated from
32P-labeled, VR1-transfected cells, displayed high levels PKA in vitro phosphorylation sites located on the engi-
neered cytoplasmic domains. In-gel digest with Lys-Cof basal 32P incorporation (Figure 1C). Surprisingly, 8Br-
cAMP had little effect on basal phosphorylation (Figures followed by HPLC of the N-terminal protein revealed
three major radioactive phosphopeptide peaks (Figure1C and 1D). This may indicate that PKA does not phos-
phorylate VR1, that basal VR1 phosphorylation saturates 3A). Sequencing of these fractions coupled with scintil-
lation counting of the sequencing cycles revealedPKA sites on VR1, or that PKA phosphorylation may
only become significantly obvious in the desensitized Thr144, Thr370, and Ser6 as phosphorylation sites (Fig-
ures 3B–3D). However, significant radioactivity re-state. Since our physiology experiments suggested that
PKA attenuates VR1 desensitization, we pursued the mained on the sequencing filter from peak 2, indicating
the major phosphorylation site in this HPLC fraction waslast possibility and examined VR1 phosphorylation after
PKA Phosphorylation and Modulation of VR1
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Figure 2. The N terminus, C terminus, and First Intracellular Loop of VR1 Are Substrates for PKA Phosphorylation
(A) Schematic representation of VR1 membrane topology with two large N- and C-terminal cytoplasmic domains and two smaller intracellular
loops. Three fragment proteins (shaded gray circles) were generated for in vitro phosphorylation analysis. The N- and C-terminal proteins
were produced as GST fusion proteins, while the first intracellular loop was manufactured as a peptide with the sequence CYFLQRRPSLKSLFVDSY.
The second intracellular loop does not contain any serines or threonines. (B) Coomassie blue stained gel shows successful production of
full-length N-terminal (68 kDa) and C-terminal (46 kDa) fusion proteins indicated by arrows. (C) Phosphorylation time course for 100 M
VR1 first intracellular loop peptide. (D) Time course of phosphorylation for GST VR1 N-terminal fusion protein. Reactions were incubated for
various time points, proteins separated on SDS-PAGE, and 32P transferred quantified using phosphorimaging and densitometry. Examples of
phosphorimager bands at different time points shown in inset. Saturating stoichiometry is approximately 6 pmol/g protein or 50%. (E) Time
course of phosphorylation for GST VR1 C-terminal fusion protein. Examples of bands at different time points shown in inset. Saturating
stoichiometry is approximately 6 pmol/g or 25% (mean  SEM, n  3 for all experiments).
yet to be reached and that Ser6 is an extremely minor may indicate that Ser6, Thr144, and Thr370 are the only
phosphorylation sites. ESI mass spectroscopy, althoughsite (Figure 3C). This phosphorylation site may exist far-
ther along in the same peptide or possibly in a low sensitive, can fail to identify large phosphopeptides that
fall outside the dynamic range of the 79 precursorabundance, coeluting peptide. In an attempt to obtain
smaller peptides for phosphorylation site identification, scan window. Presumably, this was the case with Ser6,
which resides in a predicted tryptic peptide of 40 resi-we conducted an in-gel trypsin digest followed by ESI
mass spectroscopy, but only found Thr144 and Thr370 dues. Furthermore, a mutant N-terminal fusion protein
with Ser6, Thr144, and Thr370 altered to alanines exhib-as phosphorylation sites (data not shown). These data
Neuron
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Figure 3. Phosphorylation Site Determination of VR1 Cytoplasmic Domains
(A) Cerenkov counting of HPLC fractions from peptides eluted after a Lys-C in-gel digest of the GST VR1 N-terminal fusion protein. Three
larger peaks (indicated by circled numbers) were selected for Edman sequencing. (B) Peak 1 Edman sequencing results correlated with
scintillation counting of sequencing cycles point to Thr144 as a phosphorylation site. (C) Peak 2 scintillation counting with Edman sequencing
suggest Ser6 as an extremely minor site with most of the counts remaining on the sequencing filter (cycle “F”). Residues indicated in italics
were not directly sequenced, but deduced from the predicted peptide. (D) Edman sequencing coupled with scintillation counting of peak 3
identified Thr370 as a phosphorylation site. Residues in italics were deduced from the predicted peptide, while other resides were explicitly
sequenced. (E) Cerenkov counting of HPLC fractions from an in-gel Asp-N digest of the GST VR1 N-terminal mutant fusion protein with S6A,
T144A, and T370A. A single phosphopeptide peak can be identified. (F) Scintillation counting of Edman sequencing cycles correlated with
PKA Phosphorylation and Modulation of VR1
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ited no decrement in phosphorylation stoichiometry 1D), a working hypothesis emerges that functional sensi-
tization and desensitization are related to phosphory-(Figure 3G). Considering these findings, we hypothe-
sized that a major phosphorylation site remained un- lated and dephosphorylated states of the VR1 protein,
respectively. Using this hypothesis as a guide, weidentified.
We pursued the putative missing site by conducting sought to elucidate the functional roles of the biochemi-
cally determined PKA phosphorylation sites in the nativean Asp-N in-gel digest of a mutant N-terminal protein
with Ser6, Thr144, and Thr370 altered to alanines. Ceren- VR1 protein. Initially, inactivating or “constitutively de-
phosphorylated” alanine mutations were created in eachkov counting of the HPLC fractions yielded a highly
of the key serine and threonine residues and capsaicinphosphorylated peptide (Figure 3E), which upon se-
responses of cells transiently expressing each mutantquencing revealed Ser116 as the phosphorylation site
determined by electrophysiology. Based on our starting(Figure 3F). Although HPLC fraction radioactivity is not
hypothesis, we expected two possible results. One pos-equivalent to stoichiometry due to variation in gel elu-
sibility was that the dephosphorylated mutant is equiv-tion, the Ser116 phosphopeptide radioactivity peak is
alent to or reproduces the desensitized state. Thisabout one order of magnitude larger than the previous
hypothesis predicts small currents, which fail to desen-peaks attributed to Thr144 or Thr370, suggesting Ser116
sitize any further. Another possibility was that dephos-may be the major N-terminal phosphorylation site. In-
phorylation enhances the rate of entry or decreases thedeed, PKA phosphorylation of the single Ser116Ala mu-
rate of exit from desensitized states. In this case, atant fusion protein was almost 70% less than wild-type
dephosphorylated mutant may show normal currents(Figure 3G).
with exaggerated desensitization.The first intracellular loop contains two potential PKA
Both current density (pA/pF) of the initial capsaicinphosphorylation sites, Ser502 and Ser505, based simply
response and the degree of desensitization for the sec-on proximity to positively charged residues. In order to
ond of two consecutive capsaicin applications were as-differentiate these sites, phosphorylated peptide was
sessed for wild-type, S6A, S116A, T144A, T370A, S502A,sequenced by Edman degradation, and scintillation
S774A, and S820A mutants. Desensitization was signifi-counting of the cycles clearly delineated Ser502 as the
cantly altered in several mutants (Figure 4A). S774A andPKA phosphorylation site (Figure 3H).
S820 appeared to follow one prediction with enhancedPhosphorylation sites on the C-terminal intracellular
desensitization, while T144A fit the other prediction, ex-domain protein were identified using ESI mass spectros-
hibiting little desensitization. However, desensitizationcopy. Peptides from an in-gel trypsin digest of the phos-
seemed to be related to initial current density, such thatphorylated C-terminal protein were subjected to a 79
mutants with lower current densities desensitized lessprecursor ion scan, which delineated two major phos-
than mutants with large current densities (compare Fig-phopeptides (Figure 3I). Tandem MS/MS sequencing of
ures 4A and 4B). Even for wild-type VR1, a scatter plot ofthese peptides identified Ser774 and Ser820 as PKA
current density versus desensitization reveals a strongphosphorylation sites. Altering Ser774 and Ser820 to
negative correlation for responses with transiently trans-alanines eliminated phosphorylation (mutant phosphor-
fected (open circles) or stably transfected (filled circles)ylation was 9.2% of wild-type, n3) indicating complete
cells (Figure 4C). This finding is expected given the nu-identification of PKA phosphorylation sites (Figure 3J).
merous studies which have demonstrated a correlationTaken together, based on required kinase concentra-
between capsaicin-based calcium influx and desensiti-tions and stoichiometry estimates, we can qualitatively
zation in cultured sensory neurons (Cholewinski et al.,identify Ser116 and Ser502 as major in vitro PKA phos-
1993; Docherty et al., 1996; Liu and Simon, 1996; Piperphorylation sites and Thr144, Thr370, Ser774, Ser820,
et al., 1999). Thus, the apparent differences in desensiti-and possibly Ser6 as minor sites. Ser502 requires ap-
zation amongst the inactivating mutants probably reflectproximately 50- to 100-fold less kinase to achieve satu-
differences in current density rather than phosphoryla-rating phosphorylation, while Ser116 accounts for the
tion-mediated changes in desensitization. Indeed, whenlargest single site stoichiometry (35%).
mutant desensitization is plotted against current den-
sity, the mutants lie along the regression line determined
Functional Characterization of PKA for wild-type VR1 (Figure 4D).
Phosphorylation Site Mutants We hypothesized that differences in current density
Given the functional evidence that PKA-mediated phos- simply reflected changes in surface expression, thereby
phorylation can rescue VR1 from agonist-induced de- correspondingly changing VR1-mediated calcium influx.
sensitization (Figure 1B) and that VR1 itself is dephos- We utilized cell surface biotinylation and streptavidin
precipitation to examine surface expression of wild-phorylated upon agonist stimulation (Figures 1C and
sequencing results for the single peak from (E) delineates Ser116 as the phosphorylation site. Residues in italics were deduced, while
others were directly sequenced. (G) Phosphorylation stoichiometry for mutant GST VR1 N-terminal fusion proteins. Fusion proteins were
phosphorylated for 1.5–2 hr and stoichiometry quantified as the percentage of wild-type phosphorylation conducted simultaneously (mean 
SEM, n  3 for all constructs). (H) Scintillation counting of Edman sequencing cycles for phosphorylated VR1 first intracellular loop peptide.
Results clearly delineated Ser502 as the major phosphorylation site rather than Ser505. (I) ESI mass spectroscopy 79 precursor ion scan of
peptides from an in-gel trypsin digest of the GST VR1 C-terminal fusion protein identified two major phosphate-associated peptides. Tandem
MS/MS sequencing of these peptides directly identified Ser774 (peptide m/z 901.3) and Ser 820 (peptide m/z 899.1) as phosphorylation sites.
(J) Phosphorylation of mutant GST VR1 C-terminal fusion protein with S774A and S820A eliminated 32P incorporation. Mutant phosphorylation
was 9.2% of wild-type (n  3).
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Figure 4. Current Density and Desensitization in PKA Phosphorylation Site Mutants
Normalized second capsaicin responses (A, see legend for Figure 1B) and current density values for the initial capsaicin response (B) for
wild-type VR1 and the indicated PKA site mutants transiently expressed in CHO-K1 cells. Mutants are ordered by increasing current density.
Number of cells indicated above each bar. * indicates significant difference from wild-type (ANOVA, post hoc Dunnett’s test, p  0.05). (C)
Correlation plot of normalized second responses versus current density from CHO-K1 cells expressing wild-type VR1 either transiently (open
circles, n  37) or stably (filled circles, n  21). The straight line is a linear regression fit to all of the wild-type data points with an r2  0.34.
(D) Correlation plot of normalized second capsaicin response (A) versus initial response (B) for the indicated mutant receptors (gray triangles,
mean  SEM). The straight line is the regression fit from panel C. (E) Western blot of total and surface expressed wild-type, T144A, and T144D
VR1 using an anti N-terminal VR1 antibody (1:1000) following surface biotinylation of cells transfected with each receptor or mock transfection
control (see Experimental Procedures for details). (F) Relative surface expression of PKA site mutants plotted as the ratio of mutant to wild-
type expression in the biotinylated pool normalized for total input loading (mean  SEM, n  5).
type, T144A, and T144D VR1 receptors. The T144 mu- PKA-Dependent Sensitization
of VR1 Requires Ser116tants exhibit varying degrees of current amplitude defi-
cits measured as decreased current density (Figure 4B) Since none of the inactivating mutants exhibited phos-
phorylation-based changes in desensitization, we hy-and reduced proportion of cells responding to 1 M
capsaicin (29/29 for wild-type VR1, 13/34 for T144A, and pothesized that PKA phosphorylation of VR1 may pre-
vent desensitization, while dephosphorylation at a6/13 for T144D) or pH 5 (15/15 for wild-type, 3/12 for
T144A, and 6/10 for T144D). Correlating well to current particular site may simply be permissive to desensitiza-
tion. Using this rationale, we constructed aspartate mu-density, T144A showed heavily reduced surface expres-
sion, while T144D exhibited moderately diminished sur- tants, which mimic a “constitutively phosphorylated”
state, and hypothesized that a functionally relevant siteface expression compared to wild-type (Figures 4E and
4F). Pilot studies with S6A, T370A, S502A, and S820A would exhibit little desensitization. We returned to re-
sults from the in vitro biochemistry and focused ourshowed similar results with surface expression varying
between 60% and 130% compared to wild-type (data attention on aspartate mutants at the qualitatively signif-
icant phosphorylation sites of Ser116 and Ser502.not shown).
PKA Phosphorylation and Modulation of VR1
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Figure 5. Phosphorylation of Ser116 Medi-
ates PKA Reversal of VR1 Desensitization
(A) Normalized second capsaicin responses
for wild-type, S116D, and S502D mutants.
* denotes significantly different values from
wild-type (ANOVA, post hoc Dunnett’s Test,
p  0.05). (B) VR1 aspartate mutants plotted
against regression line describing relation-
ship of desensitization versus current density
for wild-type VR1 as defined in Figure 4C.
(C) Sample recordings of responses to two
consecutive applications of capsaicin (1 M,
20 s) from CHO cells expressing wild-type
VR1 or the PKA site mutants S116A and
S116D. Recordings were obtained under ei-
ther control conditions or following 30 min
preincubation with 1 mM 8Br-cAMP as indi-
cated. (D) The ratio of the second to the initial
capsaicin response (mean  SEM) is plotted
for wild-type VR1 and the indicated PKA site
mutants with () or without () preincubation
with 8Br-cAMP. Numbers of cells indicated
above each bar. * indicates significantly dif-
ferent values from respective control (without
8Br-cAMP) values (ANOVA, post hoc Tukey’s
comparisons, p  0.05).
We again assessed the degree of desensitization by vents normal desensitization of wild-type VR1, it com-
pletely fails to alter desensitization of the S116A mutantcomparing the second of two responses to capsaicin
to the initial response for cells transiently transfected (Figures 5C and 5D). Conversely, 8Br-cAMP treatment
dramatically inhibits desensitization in all of the otherwith S116D and S502D. While S502D desensitization
was indistinguishable from wild-type, S116D exhibited desensitizing mutants, including the high current den-
sity, heavily desensitizing S774A and S820A mutantsstrongly blunted desensitization, mimicking wild-type
VR1 after 8Br-cAMP treatment (Figures 5A and 5C). (Figure 5D). Taken together, these data strongly support
an exclusive role for Ser116 in PKA-mediated regulationAgain, reduced desensitization of S116D may simply
reflect lower current density. However, when plotted on of VR1 sensitivity to capsaicin.
Given that desensitization and its regulation may bethe regression curve describing the relationship be-
tween desensitization and current density (see Figure ligand specific, we wanted to verify that our results were
generally applicable to other ligands such as protons,4), S116D shows a significant deviation from wild-type
(Figure 5B). Thus, S116D truly mimics nondesensitizing which activate VR1 at a different locus (Jordt et al., 2000;
Welch et al., 2000) and presumably activate VR1 in vivo.currents seen with wild-type currents following 8Br-
cAMP treatment. As seen with capsaicin responses, VR1 pH responses
also desensitize, and this desensitization is preventedAlthough the use of mimicking mutants is relatively
clear in terms of expected results, a positive result as by PKA activation with 8Br-cAMP (Figures 6A and 6B).
H89, a PKA inhibitor, blocked 8Br-cAMP-mediated re-seen with Ser116 may not be specific to phosphorylation
by PKA. To confirm the role of Ser116 in PKA-mediated versal of proton response desensitization (Figure 6B).
Furthermore, the S116D mutant exhibited reduced de-regulation of VR1 desensitization, we returned to the
inactivating mutants and pre-treated cells with 8Br- sensitization of proton responses, while the S116A mu-
tation abrogated the effect of 8Br-cAMP on proton re-cAMP (1 mM, 30 min) to assess the ability of PKA to
reduce desensitization. While 8Br-cAMP treatment pre- sponses as seen for capsaicin responses (Figures 6C
Neuron
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Figure 6. PKA Reverses VR1 Proton Re-
sponse Desensitization by Phosphorylation
of Ser116
(A) Inward current responses to consecutive
applications of pH 5.0 external solution in
CHO-K1 cells transiently expressing wild-
type VR1. The upper responses are from a
control cell, while the lower responses from
a cell preincubated for 30 min in 1 mM 8Br-
cAMP. (B) The ratio (mean  SEM) of the
second to the first of two consecutive 60 s
applications of pH 5.0 external solution is
plotted for CHO-K1 cells expressing wild-
type VR1 under control conditions (open bar),
following 30 min preincubation with 1 mM
8Br-cAMP (black bar), or following 8Br-cAMP
incubation in the presence of 1M H-89 (gray
bar). Asterisks indicate difference versus
control (ANOVA, post hoc Tukey’s compari-
sons, p 0.05). (C) Current responses to con-
secutive pH 5.0 application in CHO-K1 cells
transiently expressing the VR1 mutants
S116D (upper recording), S116A (middle re-
cording), and S116A following a 30 min prein-
cubation with 1 mM 8Br-cAMP (lower re-
cording). (D) The ratio (mean  SEM) of the
second to the first of two consecutive appli-
cations of pH 5.0 to CHO-K1 cells expressing
either wild-type, S116A, or S116D VR1 and
with or without 8Br-cAMP preincubation as
indicated. Asterisks indicate difference ver-
sus wild-type control (ANOVA, post hoc Tu-
key’s comparisons, p  0.05).
and 6D). These results suggest that the effects of PKA 7C). These data suggest that Ser116 is one of several
sites dephosphorylated by capsaicin and the major siteactivation and Ser116 are ligand independent and rele-
vant to endogenous regulation of VR1 function. through which phosphorylation by PKA reverses capsa-
icin-induced dephosphorylation.To biochemically address the role of Ser116 as a PKA
substrate, we immunoprecipitated S116A from trans-
fected cells following 32P labeling. 32P-labeled, S116A Discussion
exhibited significantly less capsaicin-induced dephos-
phorylation than wild-type VR1 (Figures 7A and 7B) and In this study, we identify VR1 as a PKA substrate in
vivo and identify Ser116 as a functionally relevant PKAno significant reversal of capsaicin-induced dephos-
phorylation with 8Br-cAMP treatment (Figures 7A and phosphorylation site. Our cellular phosphorylation data
Figure 7. VR1 S116A Exhibits Little Reversal
of Capsaicin-Induced Dephosphorylation by
8Br-cAMP
(A) S116A VR1 was immunoprecipitated from
transiently transfected, 32P-orthophosphate-
labeled COS7 cells and separated by SDS-
PAGE. VR1 bands detected with phos-
phorimaging after various treatments (see
Figure 1 legend for details) are shown. (B)
Capsaicin-induced dephosphorylation (1 
capsaicin treated/vehicle  100%) is de-
creased in S116A compared to wild-type
(mean  SEM, n  4 for wild-type, n  3 for
S116A, * unpaired t test, p  0.05). (C) No
significant difference exists in VR1 32P incor-
poration between capsaicin and 8Br-cAMP
treated S116A transfected cells (mean 
SEM, n 3 for capsaicin, n 4 for Cap8Br-
cAMP, unpaired t test).
PKA Phosphorylation and Modulation of VR1
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indicated that PKA activation preferentially blunts cap- tion to prevention of VR1 desensitization, we cannot
saicin-induced dephosphorylation. This work provides completely rule out that the other identified sites may
evidence of dephosphorylation of VR1 with desensitiz- mediate unidentified functions. Conversely, these sites
ing capsaicin applications at the biochemical level. Pre- may represent artifacts restricted to in vitro phosphory-
vious studies in dorsal root ganglion neurons have lation and unseen in the native receptor, a potential issue
shown that calcineurin phosphatase inhibitors reduce when utilizing this approach for the study of receptor
acute desensitization, and pipette solutions containing phosphorylation (Mammen et al., 1999).
ATP prevent tachyphylaxis of capsaicin responses This work establishes VR1 as a substrate for PKA.
(Docherty et al., 1996; Koplas et al., 1997; Piper et al., Given the prominent roles for PKA and VR1 in inflamma-
1999). These data suggest that VR1 dephosphorylation tory hyperalgesia, VR1 may act as a PKA substrate dur-
may be mechanistically linked to desensitization. How- ing inflammatory pain states. Specifically, PKA phos-
ever, capsaicin response desensitization is a complex phorylation at Ser116 may maintain VR1 function in the
process with varying kinetic components. A fast compo- midst of desensitizing, chronic stimulation from protons
nent appears to be dependent on intracellular calcium, released after tissue injury. This can contribute directly
voltage, and calcineurin activity, while a slower compo- to changes in thermal sensitivity or maintain neurogenic
nent appears at least to be ATP dependent (Docherty components of inflammation, such as peptide release
et al., 1996; Koplas et al., 1997; Liu and Simon, 1996; from primary afferent terminals. Future studies will focus
Piper et al., 1999; Tominaga et al., 1998). Further com- on the functional consequences of Ser116 phosphoryla-
plexity is overlaid by the interactions between these tion at the cellular and behavioral level in physiologic
factors, such as voltage-dependent calcium influx and and pathologic pain states.
calcium-dependent phosphatase activity. Our data also
suggest a relationship between VR1 surface expression
Experimental Proceduresand desensitization. While the correlation between cur-
rent density and desensitization for wild-type VR1 is
32P Metabolic Labeling and VR1 Immunoprecipitation
suggestive, only the direct examination of surface ex- COS7 cells maintained in Dulbecco’s Minimal Essential Media
pression afforded by the mutants allowed us to correlate (DMEM)  10% FBS were plated onto 6 well plates and transfected
surface expression with current density and desensitiza- with pCDNA3 VR1 using Lipofectamine 2000 as per manufacturer’s
tion. Considering the several factors affecting VR1 de- protocol (Invitrogen, Carlsbad, CA). About 36 hr after transfection,
cells were rinsed with phosphate-free Minimal Essential Media withsensitization, it seems most likely that the level of sur-
Earle’s salts (P-EMEM; Sigma, St. Louis, MO) and incubated withface expression alters capsaicin-induced calcium influx
P-EMEM containing 250 Ci/ml 32P-orthophosphate for 4 hr. Eitherto indirectly modulate the level of desensitization. These
10 mM Tris (pH 8) vehicle or 1 mM 8Br-cAMP was added to the
data also underscore the importance of considering the media and incubated for 15 min. Thereafter, 0.1% EtOH vehicle, 1
surface expression of VR1 mutants when interpreting M capsaicin alone, or capsaicin plus 8Br-cAMP dissolved in patch-
their effects on VR1 function. clamp external solution (see below) were applied for 5 min. Cells
This study represents a first step in examining the were lysed in 500 l lysis buffer (LYB—50 mM NaCl, 50 mM NaF,
25 mM Na-phosphate [pH 7.4], 2.5 mM EDTA, 1% Triton-X, 10 mMeffect of VR1 phosphorylation on desensitization. Our
Na-pyrophosphate, 2 mM Na-orthovanadate, 0.1 mM PMSF, 10data suggests that Ser116 is dephosphorylated by cap-
g/ml leupeptin, 5 g/ml aprotinin, 10 g/ml pepstatin, 1 M micro-saicin and that PKA regulates VR1 desensitization by
cystin-LR) and centrifuged at 14,000 rpm in a microcentrifuge for
Ser116 phosphorylation. However, an inactivating ala- 15 min at 4C. The supernatant was pre-cleared with 25 l protein
nine mutant at Ser116 has little effect on desensitization, A Sepharose (Pierce, Rockford, IL). Two to three micrograms of
suggesting that Ser116 dephosphorylation is not rate affinity-purified rabbit anti-VR1 C-terminal peptide antibody (raised
limiting to desensitization. Dephosphorylation at other to CLKPEDAEVFKDSMVPGEK) was added to the lysate and incu-
bated overnight at 4C. Antibody-antigen complexes were collectedsites, which continues to occur in this mutant, as well as
with 25 l protein A Sepharose for 3 hr. Beads were rinsed threecalcium- and voltage-dependent steps, may represent
times with 1 ml LYB, twice with high ionic strength buffer (LYB butrate-limiting steps in the desensitization process. While
with 500 mM NaCl), and twice with low ionic strength buffer (LYBdephosphorylation at Ser116 is not rate limiting, Ser116
without NaCl and Na-phosphate replaced with 20 mM Tris [pH 6.8]).
phosphorylation either through PKA activation or through Immunoprecipitated VR1 was released with SDS sample buffer con-
a mimicking aspartate mutant prevents desensitization. taining 25 mM DTT and alkylated with subsequent addition of 50
Therefore, the Ser116 dephosphorylated and phosphor- mM iodoacetamide. Samples were electrophoresed on 8% SDS-
PAGE gels and radiolabeled VR1 was detected by phosphorimagingylated forms of VR1 do not represent desensitized and
(Packard Instruments, Meridian, CT). Densities were normalized tosensitized states of VR1, respectively, but rather a gate
total 32P incorporation.mechanism in which entry into desensitized states is
prevented by phosphorylation and allowed to occur with
dephosphorylation. Future studies will examine interac- GST Fusion Protein Production
tions between the phosphorylation state of Ser116, cal- The cytoplasmic N- and C- terminal domains (amino acids 1–432
cium, voltage, and phosphorylation at other sites. and 686–838, respectively) were cloned into pGex-4T1 at the XhoI
In pinpointing the locus of PKA action, in vitro phos- site using PCR. GST fusion proteins were produced in the BL21 RP
E. coli bacterial strain (Stratagene, La Jolla, CA) by inducing proteinphorylation of engineered cytoplasmic domains and
production with 0.1 mM IPTG at room temperature for 4–5 hr. Bacte-protein sequencing revealed several PKA phosphoryla-
ria were lysed using lysozyme treatment (Witholt et al., 1976) andtion sites. However, only Ser116 mutants demonstrated
sonication, and fusion proteins were purified using GSTrap FF 1 mlfunctional effects completely consistent with phosphor-
columns according to manufacturer’s instructions (Amersham-Phar-
ylation. A loss-of-function alanine mutant exhibited no macia, Piscataway, NJ). After elution with 10 mM reduced glutathi-
PKA-dependent modulation, while a negative charge one, fusion proteins were concentrated to0.5–3 mg/ml using Cen-
conferring aspartate mutant mimicked PKA modulation. tricon ultrafiltration devices (Millipore, Bedford, MA) and centrifuged
at 100,000  g for 60 min to pellet aggregated protein and debris.While we can confidently attribute Ser116 phosphoryla-
Neuron
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In Vitro Phosphorylation of Fusion Proteins Surface Biotinylation Assay
CHO-K1 cells expressing wild-type or mutant VR1 were grown inand Synthetic Peptide
Phosphorylation reactions consisted of 100 M peptide or 1.8 M 35 mM dishes, rinsed in PBS, and incubated with NHS-SS-biotin
(Pierce, 1.5 mg/ml) for 1 hr at 4C. The biotinylation reaction wasfusion protein (0.1 mg/mL), 50 mM Tris-Cl (pH 7.5), 1 mM EDTA
(pH 8), 12 mM Mg-acetate, 0.25 mM ATP, 1 Ci/L 	-32P-ATP quenched with 100 mM glycine in PBS, then the cells were washed,
lysed in RIPA buffer, and centrifuged (20,000  g) for 30 min. The(4000–8000 cpm/pmol ATP), and 0.01 U/l (peptide) or 1 U/l
(fusion proteins) bovine heart protein kinase A catalytic subunit supernatant was removed and incubated with streptavidin beads
(Sigma, St. Louis, MO) for 1 hr at room temperature. The beads were(Sigma, St. Louis, MO), and were incubated at 30C. Reactions were
stopped at various time points by spotting onto P81 phosphocellu- then spun down to separate proteins associated with the surface
membrane from those in the cytosol or intracellular vesicles (super-lose paper (peptide) or by adding an equal volume of 2 sample
buffer and boiling for 5 min (fusion proteins). P81 squares with natant). After washing the beads three times in RIPA buffer, biotinyl-
ated proteins were eluted with sample buffer and both supernatantblotted peptides were washed several times in 75 mM phosphoric
acid, dried with methanol, and placed into 10 ml scintillation fluid. and eluted proteins were subjected to SDS-PAGE and Western blot
with a VR1 N-terminal antibody.Fusion proteins were electrophoresed on SDS-PAGE gels, stained
with Coommassie blue, and quantified using nearby BSA standards.
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